Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo's Tivicay Gets Approval
Yahoo/Zacks
Saturday, August 17, 2013 - 11:24am
tags:
HIV, GSK, Tivicay
Is This New Lung Cancer Treatment a Game Changer?
Motley Fool
Saturday, August 17, 2013 - 11:23am
tags:
Eli Lilly, lung cancer, necitumumab
2 Drug Companies to Buy and 1 to Sell
Motley Fool
Saturday, August 17, 2013 - 11:22am
tags:
Sanofi, Gilead Sciences, AbbVie
Exclusive: FDA says working with Merck, USDA on cattle drug Zilmax
Yahoo/Reuters
Saturday, August 17, 2013 - 11:21am
tags:
Merck, Zilmax, FDA
A Closer Look at 3 Players in Diabetes Treatments
Motley Fool
Saturday, August 17, 2013 - 10:54am
tags:
type 2 diabetes, type 1 diabetes, Osiris Therapeutics, MannKind, diabetes, NovoNordisk
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, August 17, 2013 - 10:52am
tags:
Osiris Therapeutics, Anacor, Novavax
Which Of These Smaller Companies Could Roche Buy?
Motley Fool
Saturday, August 17, 2013 - 10:50am
tags:
Roche, M&A, Celldex, ImmunoCellular Therapeutics, Immunomedics, Alexion
Inovio's Price Spike And The Future Of DNA Vaccines
Seeking Alpha
Saturday, August 17, 2013 - 10:48am
tags:
Inovio, vaccines, DNA vaccines
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, August 17, 2013 - 10:47am
tags:
Merrimack Pharmaceuticals, MannKind, Synta Pharmaceuticals
2 Takeaways From Illumina's Earnings
Motley Fool
Saturday, August 17, 2013 - 10:45am
tags:
Illumina, earnings
BioMarin Announces Oral Presentation of BMN 673 Most Recent Data on Breast and Ovarian Cancers at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Saturday, August 17, 2013 - 10:42am
tags:
Biomarin, BMN 673, breast cancer, ovarian cancer
Amgen's Focus On Kyprolis Data Shows Need To Aspire
Seeking Alpha
Saturday, August 17, 2013 - 10:41am
tags:
Amgen, Kyprolis, Onyx, Hemerus Medical M&A
Fibrocell Science Steadies Itself For Growth After Listing On NYSE
Seeking Alpha
Saturday, August 17, 2013 - 10:39am
tags:
Fibrocell Science
Positive Data on MannKind's Afrezza
Yahoo/Zacks
Saturday, August 17, 2013 - 10:38am
tags:
MannKind, diabetes, Afrezza, type 2 diabetes
Is This Myelofibrosis Drug a Blockbuster?
Motley Fool
Saturday, August 17, 2013 - 10:36am
tags:
myelofibrosis, Jakafi, Incyte
Merck suspends sales of Zilmax, to study use of cattle product
Reuters
Friday, August 16, 2013 - 11:03am
tags:
Merck, Zilmax, animal health
US FDA approves Silvergate Pharmaceuticals' Epaned to treat hypertension
Pharmaceutical Business Review
Friday, August 16, 2013 - 10:56am
tags:
Silvergate Pharmaceuticals, Epaned, pediatric hypertension, FDA
Avanir, Sandoz settle Nuedexta patent litigation
Pharmaceutical Business Review
Friday, August 16, 2013 - 10:55am
tags:
Avanir, Sanzoz, patents, generics, Novartis, Nuedexta
Bayer Reports $1.4 Billion in Yaz and Yasmin Settlements
Injury Lawyer News
Friday, August 16, 2013 - 10:54am
tags:
Bayer, Yaz, Yasmin, settlements
Ophthotech eyes $85M IPO to fund PhIII for drug to prevent blindness
Fierce Biotech
Friday, August 16, 2013 - 10:51am
tags:
wet age-related macular degeneration, Ophthotech, IPOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.